Testing for Diagnosis of Active or Latent Tuberculosis
This policy defines Blue Cross Blue Shield of New Mexico's reimbursement criteria for laboratory testing used to diagnose or screen for active and latent tuberculosis and specifies which tests may or may not be reimbursed for covered members.
Added new CPT code 87564 effective 01/01/2025.
Document updated with literature review; reimbursement information revised for clarity on multiple dates.
Reimbursement Information: combined items #2 and #3 and clarified reimbursable tests for suspected TB infections; added molecular-based DST reimbursement criteria for certain patients.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.